Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort
- PMID: 25838066
- DOI: 10.1001/jamaophthalmol.2015.0498
Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort
Abstract
Importance: The natural course and prognosis of medium drusen and risk factors associated with the incidence and progression of this lesion type in age-related macular degeneration (AMD) are not well understood.
Objective: To assess the 15-year incidence and progression of medium drusen and associated risk factors.
Design, setting, and participants: Population-based cohort in the Blue Mountains region, west of Sydney, Australia. Included in the study were 3654 participants 49 years or older who attended baseline examinations of the Blue Mountains Eye Study (1992-1994), and 75.8%, 76.7%, and 56.1% of survivors who attended the 5-year, 10-year, and 15-year follow-up examinations, respectively.
Main outcomes and measures: Color retinal fundus photographs were obtained at each examination. The incidence and progression of medium drusen (maximum diameter, 63 to <125 µm) were assessed using Kaplan-Meier product-limit survival methods, controlling for competing risk of death. Factors associated with a 15-year incidence of medium drusen were assessed using discrete logistic regression models after adjusting for age, sex, smoking status, serum lipid levels, systemic and dietary factors, and CFH rs1061170 and ARMS2 rs10490924 polymorphisms. Associations between lesion characteristics and the progression to late AMD were assessed using generalized estimating equation models and eye-specific data.
Results: Among 1317 participants at risk, the 15-year cumulative incidence of medium drusen was 13.9% (n = 281). Increasing age (per decade older) (odds ratio [OR], 1.4; 95% CI, 1.2-1.8) and the presence of at least 3 risk alleles of the CFH rs1061170 or ARMS2 rs10490924 genes (OR, 2.1; 95% CI, 1.1-4.1) were associated with a higher incidence. There was no association between past smoking (OR, 0.8; 95% CI, 0.6-1.1) or current smoking (OR, 0.6; 95% CI, 0.4-1.1) and the development of medium drusen. The progression rate to late AMD in eyes with both medium drusen and retinal pigmentary abnormalities was 4-fold higher than that in eyes with medium drusen alone. Larger total area and central location of medium drusen were associated with a greater likelihood of the progression to worse stages of AMD.
Conclusions and relevance: Older age and the presence of CFH and ARMS2 risk alleles are 2 main risk factors associated with the development of medium drusen. The copresence of medium drusen plus retinal pigment epithelium abnormalities signals a greater risk of the progression to late AMD than the presence of medium drusen alone.
Similar articles
-
Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.Ophthalmology. 2014 Apr;121(4):917-25. doi: 10.1016/j.ophtha.2013.10.043. Epub 2013 Dec 12. Ophthalmology. 2014. PMID: 24332537
-
The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.Ophthalmology. 2015 Dec;122(12):2482-9. doi: 10.1016/j.ophtha.2015.08.002. Epub 2015 Sep 14. Ophthalmology. 2015. PMID: 26383995
-
Incidence and progression of geographic atrophy: observations from a population-based cohort.Ophthalmology. 2013 Oct;120(10):2042-50. doi: 10.1016/j.ophtha.2013.03.029. Epub 2013 May 22. Ophthalmology. 2013. PMID: 23706948
-
Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.Acta Ophthalmol. 2018 Mar;96(2):e105-e110. doi: 10.1111/aos.13494. Epub 2017 Jun 8. Acta Ophthalmol. 2018. PMID: 28593728 Review.
-
Complement factor H in AMD: Bridging genetic associations and pathobiology.Prog Retin Eye Res. 2018 Jan;62:38-57. doi: 10.1016/j.preteyeres.2017.09.001. Epub 2017 Sep 18. Prog Retin Eye Res. 2018. PMID: 28928087 Free PMC article. Review.
Cited by
-
Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO211-BIO226. doi: 10.1167/iovs.17-21872. Invest Ophthalmol Vis Sci. 2017. PMID: 28785769 Free PMC article.
-
Systemic Dyslipidemia in Age-related Macular Degeneration: An Updated Systematic Review and Meta-analysis.Ophthalmol Sci. 2023 May 31;4(1):100341. doi: 10.1016/j.xops.2023.100341. eCollection 2024 Jan-Feb. Ophthalmol Sci. 2023. PMID: 37869027 Free PMC article. Review.
-
Role of microperimetry in evaluating disease progression in age-related macular degeneration: a scoping review.Int Ophthalmol. 2022 Jun;42(6):1975-1986. doi: 10.1007/s10792-021-02170-9. Epub 2022 Jan 7. Int Ophthalmol. 2022. PMID: 34994874 Free PMC article.
-
Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.Ophthalmology. 2017 May;124(5):644-656. doi: 10.1016/j.ophtha.2016.12.034. Epub 2017 Jan 30. Ophthalmology. 2017. PMID: 28153442 Free PMC article.
-
Genetic Susceptibility, Diet Quality, and Two-Step Progression in Drusen Size.Invest Ophthalmol Vis Sci. 2020 May 11;61(5):17. doi: 10.1167/iovs.61.5.17. Invest Ophthalmol Vis Sci. 2020. PMID: 32407518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous